Joel Lewis, President and CEO: Galectin Therapeutics GALT Buy · Filed 23/02/21

Trade details

Type: Insider buy
Amount: $1,520
Shares · price: 1,000 sh · $1.52 a share
Held after: 1,000 sh
Stock: Galectin Therapeutics GALT
Person: Joel LewisPresident and CEO
Trade date: 23/02/16
Filed: 23/02/21
Days to filing: 5 days

2 insiders bought this week

Insiders buying this week: 2 insiders

Galectin Therapeutics trades, last 26 weeks

What else happened in Galectin Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/17~23/03/18

Joel Lewis's recent trades

Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$135K
37,698 sh
$135K
Filed 01/06
Traded 01/06
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$108.4K
27,731 sh
$108.4K
Filed 01/06
Traded 01/05
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$78K
18,571 sh
$78K
Filed 01/06
Traded 01/02
Joel LewisPresident and CEO
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$352.8K
84,000 sh
$352.8K
Filed 01/02
Traded 01/02
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$55.3K
7,829 sh
$55.3K
Filed 25/12/19
Traded 25/12/17

Joel Lewis, CEO — bought $1,520 of Galectin Therapeutics GALT · 1,000 sh @ $1.52 | Whalegun